The stock could see a more than 100% upside with catalysts on the horizon, the firm said.
You are here: Home / Wells Fargo says this biopharmaceutical stock could double due to drug catalysts
Market News and Views
The stock could see a more than 100% upside with catalysts on the horizon, the firm said.